Conteduca, V
71  results:
Search for persons X
?
3

Androgen receptor gain in circulating free DNA and splicing..:

Del Re, M. ; Conteduca, V. ; Crucitta, S....
Prostate Cancer and Prostatic Diseases.  24 (2021)  2 - p. 524-531 , 2021
 
?
4

Anogenital lichen sclerosus et atrophicus lesions in a case..:

Conteduca, V. ; Medri, M. ; Mazzoni, L...
Cancer Immunology, Immunotherapy.  71 (2021)  6 - p. 1545-1548 , 2021
 
?
7

2577 The correlation between circulating cell-free AR and C..:

Conteduca, V. ; Salvi, S. ; Caroli, P....
European Journal of Cancer.  51 (2015)  - p. S503-S504 , 2015
 
?
8

Impact of Candidate Genetic Polymorphisms in Prostate Cance..:

Salvi, S. ; Conteduca, V. ; Gurioli, G....
Molecular Diagnosis & Therapy.  20 (2015)  1 - p. 1-12 , 2015
 
?
9

Circulating cell-free AR and CYP17A1 copy number variations..:

Salvi, S ; Casadio, V ; Conteduca, V...
British Journal of Cancer.  112 (2015)  10 - p. 1717-1724 , 2015
 
?
10

P072 Activity and clinical outcomes of New Agents (NAs) adm..:

Caffo, O. ; De Giorgi, U. ; Fratino, L....
European Urology Supplements.  13 (2014)  5 - p. 135-136 , 2014
 
?
11

T cell receptor variable β gene repertoire in liver and per..:

Russi, S ; Lauletta, G ; Serviddio, G...
Clinical and Experimental Immunology.  172 (2013)  2 - p. 254-262 , 2013
 
?
12

Longitudinal assessment of plasma androgen receptor copy nu..:

Brighi, N ; Conteduca, V ; Gurioli, G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774884/.  , 2023
 
?
13

Serum Mass Spectrometry Proteomics and Protein Set Identifi..:

D'Arca D ; Severi L ; Ferrari S...
info:eu-repo/semantics/altIdentifier/pmid/36672361.  , 2023
 
?
14

Implementation of preventive and predictive BRCA testing in..:

Russo A ; Incorvaia L ; Capoluongo E...
info:eu-repo/semantics/altIdentifier/pmid/35597177.  , 2022
 
?
15

Combining liquid biopsy and functional imaging analysis in ..:

Conteduca V ; Scarpi E ; Caroli P...
info:eu-repo/semantics/altIdentifier/pmid/34657387.  , 2022
 
1-15